Chemoprevention in BRCA1 mutation carriers (CIBRAC): protocol for an open allocation crossover feasibility trial assessing mechanisms of chemoprevention with goserelin and anastrozole versus tamoxifen and acceptability of treatment

Aideen M Campbell, Melanie Morris, Rebecca Gallagher, Ruth Boyd, Hazel Carson, D Paul Harkin, Ewa Wielogorska, Christopher Elliott, Kienan I Savage, Stuart A McIntosh

Research output: Contribution to journalArticlepeer-review

156 Downloads (Pure)

Search results